Reduced cellular Ca2+ availability enhances TDP-43 cleavage by apoptotic caspases

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 4, 2014, Pages 725-734

  De Marco, Giovanni ^a,b   Lomartire, Annarosa ^a,b   Mandili, Giorgia ^a   Lupino, Elisa ^b   Buccinnà, Barbara ^b   Ramondetti, Cristina ^b   Moglia, Cristina ^a   Novelli, Francesco ^a   Piccinini, Marco ^b   Mostert, Michael ^c   Rinaudo, Maria Teresa ^b   Chiò, Adriano ^a   Calvo, Andrea ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Apoptosis; Ca2+ deprivation; Caspase; TDP 43 cleavage

Indexed keywords

BETA TUBULIN; CALCIUM ION; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; EDETIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; INTERLEUKIN 1BETA CONVERTING ENZYME; PROCASPASE 3; TAR DNA BINDING PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

APOPTOSIS; CA(2+) DEPRIVATION; CASPASE; TDP-43 CLEAVAGE;

ANIMALS; APOPTOSIS; CALCIUM; CASPASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE;

EID: 84893491768     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.01.010     Document Type: Article

References (63)

1. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
2. Berridge M.J. Neuronal calcium signaling. Neuron 1998, 21:13-26.
3. 2+ and synaptic plasticity. Cell Calcium 2005, 38:355-367.
4. Berridge M.J. Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 2012, 6.
5. Mattson M.P., Chan S.L. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J. Mol. Neurosci. 2001, 17:205-224.
6. Small D.H. Dysregulation of calcium homeostasis in Alzheimer's disease. Neurochem. Res. 2009, 34:1824-1829.
7. Mattson M.P. Parkinson's disease: don't mess with calcium. J. Clin. Invest. 2012, 122:1195-1198.
8. Kurnellas M.P., Donahue K.C., Elkabes S. Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers. Biochem. Soc. Trans. 2007, 35:923-926.
9. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2602-2607.
10. Delorenzo R.J., Sun D.A., Deshpande L.S. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy. Pharmacol. Ther. 2005, 105:229-266.
11. Spalloni A., Nutini M., Longone P. Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2013, 1832:312-322.
12. Appel S.H., Beers D., Siklos L., Engelhardt J.I., Mosier D.R. Calcium: the Darth Vader of ALS. Amyotroph. Lateral Scler. Other Mot. Neuron Dis. 2001, 2(Suppl. 1):S47-S54.
13. Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 2010, 47:165-174.
14. Tradewell M.L., Cooper L.A., Minotti S., Durham H.D. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention. Neurobiol. Dis. 2011, 42:265-275.
15. Chiesa R., Angeretti N., Del Bo R., Lucca E., Munna E., Forloni G. Extracellular calcium deprivation in astrocytes: regulation of mRNA expression and apoptosis. J. Neurochem. 1998, 70:1474-1483.
16. Kluck R.M., McDougall C.A., Harmon B.V., Halliday J.W. Calcium chelators induce apoptosis-evidence that raised intracellular ionised calcium is not essential for apoptosis. Biochim. Biophys. Acta 1994, 1223:247-254.
17. McGinnis K.M., Wang K.K., Gnegy M.E. Alterations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells. J. Neurochem. 1999, 72:1853-1863.
18. Han K.S., Kang H.J., Kim E.Y., Yoon W.J., Sohn S., Kwon H.J., Gwag B.J. 1,2-bis(2-Aminophenoxy)ethane-N,N,N',N'-tetraacetic acid induces caspase-mediated apoptosis and reactive oxygen species-mediated necrosis in cultured cortical neurons. J. Neurochem. 2001, 78:230-239.
19. Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 2008, 13:867-878.
20. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
21. Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., Eisen A., McClusky L., Kretzschmar H.A., Monoranu C.M., Highley J.R., Kirby J., Siddique T., Shaw P.J., Lee V.M., Trojanowski J.Q. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007, 61:427-434.
22. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
23. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M. Expression of TDP-43C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 2009, 284:8516-8524.
24. Johnson B.S., McCaffery J.M., Lindquist S., Gitler A.D. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6439-6444.
25. Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 2007, 27:10530-10534.
26. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7607-7612.
27. Rohn T.T. Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases. Histol. Histopathol. 2009, 24:1081-1086.
28. Cassel J.A., McDonnell M.E., Velvadapu V., Andrianov V., Reitz A.B. Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function. Biochimie 2012, 94:1974-1981.
29. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008, 4:e1000193.
30. Rohn T.T. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Brain Res. 2008, 1228:189-198.
31. Kokoulina P., Rohn T.T. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies. Neurodegener. Dis. 2010, 7:243-250.
32. Suzuki H., Lee K., Matsuoka M. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage. J. Biol. Chem. 2011, 286:13171-13183.
33. Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., Clark C.M., Elman L.B., Miller B.L., Grossman M., McCluskey L.F., Trojanowski J.Q., Lee V.M. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008, 173:182-194.
34. Yamashita T., Hideyama T., Hachiga K., Teramoto S., Takano J., Iwata N., Saido T.C., Kwak S. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 2012, 3:1307.
35. Pulido M.D., Parrish A.R. Metal-induced apoptosis: mechanisms. Mutat. Res. 2003, 533:227-241.
36. Caicedo M., Jacobs J.J., Reddy A., Hallab N.J. Analysis of metal ion-induced DNA damage, apoptosis, and necrosis in human (Jurkat) T-cells demonstrates Ni2+ and V3+ are more toxic than other metals: Al3+, Be2+, Co2+, Cr3+, Cu2+, Fe3+, Mo5+, Nb5+, Zr2+. J. Biomed. Mater. Res. A 2008, 86:905-913.
37. Lee J.H., Gomora J.C., Cribbs L.L., Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H. Biophys. J. 1999, 77:3034-3042.
38. Mlinar B., Enyeart J.J. Block of current through T-type calcium channels by trivalent metal cations and nickel in neural rat and human cells. J. Physiol. 1993, 469:639-652.
39. Zamponi G.W., Bourinet E., Snutch T.P. Nickel block of a family of neuronal calcium channels: subtype- and subunit-dependent action at multiple sites. J. Membr. Biol. 1996, 151:77-90.
40. Garcia-Calvo M., Peterson E.P., Rasper D.M., Vaillancourt J.P., Zamboni R., Nicholson D.W., Thornberry N.A. Purification and catalytic properties of human caspase family members. Cell Death Differ. 1999, 6:362-369.
41. De Marco G., Lupino E., Calvo A., Moglia C., Buccinna B., Grifoni S., Ramondetti C., Lomartire A., Rinaudo M.T., Piccinini M., Giordana M.T., Chio A. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011, 121:611-622.
42. Banker G.A., Cowan W.M. Rat hippocampal neurons in dispersed cell culture. Brain Res. 1977, 126:397-425.
43. Bartlett W.P., Banker G.A. An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts. J. Neurosci. 1984, 4:1944-1953.
44. Barbero G., Carta F., Giribaldi G., Mandili G., Crobu S., Ceruti C., Fontana D., Destefanis P., Turrini F. Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies. Anal. Biochem. 2006, 349:62-71.
45. Zhang H.X., Tanji K., Mori F., Wakabayashi K. Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci. Lett. 2008, 434:170-174.
46. Tsuji H., Nonaka T., Yamashita M., Masuda-Suzukake M., Kametani F., Akiyama H., Mann D.M., Tamaoka A., Hasegawa M. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Biochem. Biophys. Res. Commun. 2012, 417:116-121.
47. Nishimoto Y., Ito D., Yagi T., Nihei Y., Tsunoda Y., Suzuki N. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J. Biol. Chem. 2010, 285:608-619.
48. Brady O.A., Meng P., Zheng Y., Mao Y., Hu F. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J. Neurochem. 2011, 116:248-259.
49. Wee L.J., Tan T.W., Ranganathan S. CASVM: web server for SVM-based prediction of caspase substrates cleavage sites. Bioinformatics 2007, 23:3241-3243.
50. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
51. Inoue S., Browne G., Melino G., Cohen G.M. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ. 2009, 16:1053-1061.
52. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 2004, 10:S18-S25. (Suppl.).
53. Barber S.C., Shaw P.J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010, 48:629-641.
54. Carri M.T., Cozzolino M. SOD1 and mitochondria in ALS: a dangerous liaison. J. Bioenerg. Biomembr. 2011, 43:593-599.
55. Dupuis L., Gonzalez de Aguilar J.L., Oudart H., de Tapia M., Barbeito L., Loeffler J.P. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener. Dis. 2004, 1:245-254.
56. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
57. Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 2000, 176:88-94.
58. Takadera T., Ohtsuka M., Aoki H. Chelation of extracellular calcium-induced cell death was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells. Cell. Mol. Neurobiol. 2010, 30:193-198.
59. Kao Y.S., Fong J.C. Thapsigargin and EGTA inhibit endothelin-1-induced glucose transport. J. Biomed. Sci. 2004, 11:206-213.
60. Deniaud A., Sharaf el dein O., Maillier E., Poncet D., Kroemer G., Lemaire C., Brenner C. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 2008, 27:285-299.
61. (2+)-dependent regulation of protein phosphatase 2Ac. J. Biol. Chem. 2004, 279:51182-51192.
62. 2+ overload-mediated cell death. PLoS One 2011, 6:e20423.
63. 2+]i and glutamate neurotoxicity in vitro. J. Neurophysiol. 1994, 72:1973-1992.